The majority of modern drugs are based on phytochemicals produced from ethnomedicinal plants.This new volume provides an understanding of the importance of sustainability and bioprospecting of ethnomedicinal plants for formulating novel chemical compounds and new drugs from raw materials from plants cultivated and collected from the wild for healthcare and nutrition practices. It provides extensive information on medicinal plant diversification, cultivation techniques, biotechnological approaches, and modern and traditional usages. It also provides information for developing new strategies and formulating new policies for the systematic management and conservation of medicinal resources for future use.
Bioprospecting--the exchange of plants for corporate promises of royalties or community development assistance--has been lauded as a way to develop new medicines while offering southern nations and indigenous communities an incentive to preserve their rich biodiversity. But can pharmaceutical profits really advance conservation and indigenous rights? How much should companies pay and to whom? Who stands to gain and lose? The first anthropological study of the practices mobilized in the name and in the shadow of bioprospecting, this book takes us into the unexpected sites where Mexican scientists and American companies venture looking for medicinal plants and local knowledge. Cori Hayden tracks bioprospecting's contentious new promise--and the contradictory activities generated in its name. Focusing on a contract involving Mexico's National Autonomous University, Hayden examines the practices through which researchers, plant vendors, rural collectors, indigenous cooperatives, and other actors put prospecting to work. By paying unique attention to scientific research, she provides a key to understanding which people and plants are included in the promise of "selling biodiversity to save it"--and which are not. And she considers the consequences of linking scientific research and rural "enfranchisement" to the logics of intellectual property. Roving across UN protocols, botanical collecting histories, Mexican nationalist agendas, neoliberal property regimes, and North-South relations, When Nature Goes Public charts the myriad, emergent publics that drive and contest the global market in biodiversity and its futures.
BIOPROSPECTING OF PLANT BIODIVERSITY FOR INDUSTRIAL MOLECULES A comprehensive collection of recent translational research on bioresource utilization and ecological sustainability Bioprospecting of Plant Biodiversity for Industrial Molecules provides an up-to-date overview of the ongoing search for biodiverse organic compounds for use in pharmaceuticals, bioceuticals, agriculture, and other commercial applications. Bringing together work from a panel of international contributors, this comprehensive monograph covers natural compounds of plants, endophyte enzymes and their applications in industry, plant bioprospecting in cosmetics, marine bioprospecting of seaweeds, and more. Providing global perspectives on bioprospecting of plant biodiversity, the authors present research on enzymes, mineral micro-nutrients, biopesticides, algal biomass, and other bioactive molecules. In-depth chapters assess the health impacts and ecological sustainability of the various biomolecules and identify existing and possible applications ranging from ecological restoration to production of essential oils and cosmetics. Other topics include, bio-energy crops as alternative fuel resources, the role of plants in phytoremediation of industrial waste, and the industrial applications of endophyte enzymes. This comprehensive resource: Includes a through introduction to plant biodiversity and bioprospecting Will further the knowledge of application of different plants and improve research investigation techniques. Summarizes novel approaches for researchers in food science, microbiology, biochemistry, and biotechnology Bioprospecting of Plant Biodiversity for Industrial Molecules is an indispensable compendium of biological research for scientists, researchers, graduate and postgraduate students, and academics in the areas of microbiology, food biotechnology, industrial microbiology, plant biotechnology, and microbial biotechnology.
Ethnopharmacology and Biodiversity of Medicinal Plants provides a multitude of contemporary views on the diversity of medicinal plants, discussing both their traditional uses and therapeutic claims. This book emphasizes the importance of cataloging ethnomedical information as well as examining and preserving the diversity of traditional medicines. It also discusses the challenges present with limited access to modern medicine and the ways in which research can be conducted to enhance these modern practices. The book also explores the conservation procedures for endangered plant species and discusses their relevance to ethnopharmacology. Each chapter of this book relays the research of experts in the field who conducted research in diverse landscapes of India, providing a detailed account of the basic and applied approaches of ethnobotany and ethnopharmacology. The book reviews multiple processes pertaining to medicinal plants, such as collecting the traditional therapeutic values and validation methods. It also explores developments in the field such as the diversity and medicinal potential of unexplored plant species and applications in drug formulation to fight against anti-microbial resistance (AMR).
This module of book presented as a study material in an efforts to aid M.Sc. Botany students in their study of Bioprospecting and plant resource utilisation ( Bot - 503); and help them remember it better in study.
This volume brings together a collection of papers by some experts in medicinal plants. It is presented as a contribution to clarifying the many policy and technical issues associated with the conservation, use, production and trade of medicinal plants. This publication draws attention to the huge contribution of medicinal plants to traditional and modern health care systems, but also alert the readers on the many problems and challenges facing their sustainable development, such as: assessment and management of the medicinal plant resource base; best harvesting and processing practices; trade issues and aspects dealing with the intellectual property rights on traditional medicine by indigenous peoples. The use of this document will help raise the awareness on medicinal plants as an important forest resource, and will help ensure that medicinal plants are adequately included in forest conservation and utilization programmes.
This volume is a collection of papers by experts in medicinal plants, presented to help clarify the many policy and technical issues associated with the conservation, use, production and trade of medicinal plants. The publication draws attention to the huge contribution of medicinal plants to traditional and modern health care system. It also alerts readers on the many problems and challenges facing their sustainable development. Subjects covered include assessment and management of the medicinal plant resource base; best harvesting and processing practices; trade issues; and intellectual property rights regarding traditional medicines of indigenous peoples. This documents will help raise awareness of medicinal plants as an important forest resource and will help ensure that medicinal plants are adequately included in forest conservation and utilization programmes. Contents Chapter 1: Introduction by G C Bodeker; Part I: General Articles covering Global Issues; Forest based medicines in traditional and cosmopolitan health care by A P Van Seters, Enthnobotanical research and traditional health care in developing countries by M Balick and P A Cox, Between a rock and a hard place: Indigenous peoples, nation states and the multinationals by G Dutfield, Industrial utilisation of medicinal plants in developing countries by T de Silva, Trade in Medicinal Plants by S E Kuipers, Medicinal plant information database by K K S Bhat; Part II: Articles on Regional Aspects of Medicinal Plants Use; Biodiversity-People Interface in Nepal by N Bhattarai, Beyond the Biodiversity convention-the challenges facing the bio-cultural heritage of india s medicinal plants by D Shankar and B Majumdar, A biocultural medicinal plants conservation project in Sri Lanka by L de Alwis, utilisation and conservation of medicinal plants in China with special reference to Atractylides lancea by S-A He and N Sheng, An Africa-wide overview of medicinial plant harvesting, conservation and health care by A B Cunningham, Biodiversity conservation and the application of Amazonian medicinal plants in the control of malaria by W Milliken, Bulgarian model for regulating the trade in plant material for medicinal and other purposes by D Lange and M Mladenova, Phytomedicinal forest harvest in the United States by J A Duke.
Plants have cultural histories, as their applications change over time and with place. Some plant species have affected human cultures in profound ways, such as the stimulants tea and coffee from the Old World, or coca and quinine from South America. Even though medicinal plants have always attracted considerable attention, there is surprisingly little research on the interface of ethnobotany and medical anthropology. This volume, which brings together (ethno-)botanists, medical anthropologists and a clinician, makes an important contribution towards filling this gap. It emphasises that plant knowledge arises situationally as an intrinsic part of social relationships, that herbs need to be enticed if not seduced by the healers who work with them, that herbal remedies are cultural artefacts, and that bioprospecting and medicinal plant discovery can be viewed as the epitome of a long history of borrowing, stealing and exchanging plants.
Food security and the medicinal needs of billions of people around the world are pressing global issues, and the biodiversity and sustainable utilization of plants is of great significance in this context. Further, ethnobotanical studies are vital in the discovery of new drugs from indigenous medicinal plants, and plants with industrially important metabolites need to be cultivated to meet the growing market demand. In addition, the production of plant metabolites under in vitro conditions also has tremendous possibilities. The totipotency of plant cells plays a valuable role in the sustainable utilization of plant resources through cell, tissue and organ culture. At the same time, production can be enhanced using productive cell lines, treatment with elicitors, changing nutritional parameters and metabolic engineering. This book provides state-of-the-art information on biodiversity, conservation, ethnobotany, various aspects of In vitro secondary metabolite production, bioprospecting from various plant groups and drug discovery. It also discusses methods of extracting and characterizing drug leads from plant sources.
This book focuses on natural products, in particular medicinal plants and their derived products, as an indispensable source of bioactive molecules that serve as either drug candidates or lead compounds for drug design and discovery . There are several advantages for plant-derived therapeutics, including wide availability, diverse pharmacological actions, and a generally good profile of safety and tolerability. Over the recent years, there have been numerous reports from clinical studies testifying the efficacy and safety of medicinal plants and phytochemicals in treating human diseases. A plethora of basic studies has also unraveled molecular mechanisms underlying the health benefits of herbal medicines. Nevertheless, issues such as identification of bioactive ingredients, standardization of the products, and drug interactions remain to be systematically documented. Bioprospecting of Tropical Medicinal Plants represents a comprehensive analysis of natural products, mainly medicinal plants and phytochemicals. It includes detailed medicinal properties and pharmacological action from in vitro models to clinical trials. The goal is to present the readers a carefully curated collection of plant-derived natural products and their underlying molecular mechanisms.
